Chen B, Zhu H, Yang B, Cao J
Acta Pharm Sin B. 2023; 13(5):1976-1989.
PMID: 37250147
PMC: 10213805.
DOI: 10.1016/j.apsb.2022.11.005.
Yago M, Mehta K, Bose M, Bhagwat S, Chopra V, Dutta S
Clin Pharmacokinet. 2023; 62(5):779-788.
PMID: 37072559
PMC: 10182103.
DOI: 10.1007/s40262-023-01242-6.
Abi Habib J, Lesenfants J, Vigneron N, Van den Eynde B
Cells. 2022; 11(3).
PMID: 35159231
PMC: 8834425.
DOI: 10.3390/cells11030421.
Tripathi S, Vedpathak D, Ostrin E
Cells. 2021; 10(12).
PMID: 34944095
PMC: 8700164.
DOI: 10.3390/cells10123587.
van den Eshof B, Medfai L, Nolfi E, Wawrzyniuk M, Sijts A
Cells. 2021; 10(12).
PMID: 34943869
PMC: 8699091.
DOI: 10.3390/cells10123360.
At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention.
Tundo G, Sbardella D, Oddone F, Kudriaeva A, Lacal P, Belogurov Jr A
Cancers (Basel). 2021; 13(19).
PMID: 34638337
PMC: 8507813.
DOI: 10.3390/cancers13194852.
Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
Wada H, Shimizu A, Osada T, Tanaka Y, Fukaya S, Sasaki E
PLoS One. 2018; 13(7):e0199249.
PMID: 29969453
PMC: 6029771.
DOI: 10.1371/journal.pone.0199249.
Emerging role of immunoproteasomes in pathophysiology.
Kaur G, Batra S
Immunol Cell Biol. 2016; 94(9):812-820.
PMID: 27192937
DOI: 10.1038/icb.2016.50.
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay.
Lee S, Levitsky K, Parlati F, Bennett M, Arastu-Kapur S, Kellerman L
Br J Haematol. 2016; 173(6):884-95.
PMID: 27071340
PMC: 5074317.
DOI: 10.1111/bjh.14014.
Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Brehm A, Liu Y, Sheikh A, Marrero B, Omoyinmi E, Zhou Q
J Clin Invest. 2015; 125(11):4196-211.
PMID: 26524591
PMC: 4639987.
DOI: 10.1172/JCI81260.
Emerging roles of immunoproteasomes beyond MHC class I antigen processing.
Ebstein F, Kloetzel P, Kruger E, Seifert U
Cell Mol Life Sci. 2012; 69(15):2543-58.
PMID: 22382925
PMC: 11114860.
DOI: 10.1007/s00018-012-0938-0.
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
Kaneno R, Shurin G, Kaneno F, Naiditch H, Luo J, Shurin M
Cell Oncol (Dordr). 2011; 34(2):97-106.
PMID: 21290210
DOI: 10.1007/s13402-010-0005-5.
Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice.
Zu L, Bedja D, Fox-Talbot K, Gabrielson K, Van Kaer L, Becker L
J Mol Cell Cardiol. 2010; 49(1):5-15.
PMID: 20153750
PMC: 2883685.
DOI: 10.1016/j.yjmcc.2010.02.007.
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia.
Roccaro A, Sacco A, Aujay M, Ngo H, Azab A, Azab F
Blood. 2010; 115(20):4051-60.
PMID: 20110419
PMC: 2875093.
DOI: 10.1182/blood-2009-09-243402.
Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7.
Goubau D, Romieu-Mourez R, Solis M, Hernandez E, Mesplede T, Lin R
Eur J Immunol. 2009; 39(2):527-40.
PMID: 19152337
PMC: 2773157.
DOI: 10.1002/eji.200838832.
Intracellular peptide transporters in human--compartmentalization of the "peptidome".
Herget M, Tampe R
Pflugers Arch. 2006; 453(5):591-600.
PMID: 16710701
DOI: 10.1007/s00424-006-0083-4.
Transcription of major histocompatibility complex class I (Kb) and transporter associated with antigen processing 1 and 2 genes is up-regulated with age.
Assounga A, Warner C
Immunology. 2004; 113(3):378-83.
PMID: 15500625
PMC: 1782576.
DOI: 10.1111/j.1365-2567.2004.01967.x.
mRNA expression profiling reveals a role of Helicobacter pylori vacuolating toxin in escaping host defense.
Yuan J, Li T, Li Z, Yang G, Hu B, Shi X
World J Gastroenterol. 2004; 10(10):1528-32.
PMID: 15133867
PMC: 4656298.
DOI: 10.3748/wjg.v10.i10.1528.
The role of major histocompatibility complex molecules in luteal function.
Cannon M, Pate J
Reprod Biol Endocrinol. 2003; 1:93.
PMID: 14613531
PMC: 293428.
DOI: 10.1186/1477-7827-1-93.
Novel mechanisms of class II major histocompatibility complex gene regulation.
Radosevich M, Ono S
Immunol Res. 2003; 27(1):85-106.
PMID: 12637770
DOI: 10.1385/IR:27:1:85.